I am a PhD researcher at the Cancer Research UK (CRUK) Manchester Institute and the University of Manchester. Throughout my PhD project we aim to understand why Small Cell Lung Cancer (SCLC) patients very rapidly develop resistance to chemotherapy. To achieve this goal, we have strong collaborations with the Christie hospital on the one side and the pharmaceutical industry on the other side. We are confident to find a new treatment strategy that translates into the clinic, since the treatment regimen for SCLC has been unchanged for the last three decades.
I obtained my M.Sc. at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. During this time I not only developed a strong interest in translational research, but also had the possibility to perform several placements abroad, such as a 6-month placement at the Whitehead Institute in Boston. I believe the IF Manchester will help me to combine my strong interest in science with entrepreneurship and to translate my ideas into the clinic.